Damola Ogunleye is a recognized Quality Systems leader in Cell & Gene Therapy with over 15 years of experience building and leading GxP Quality organizations. He has driven compliance excellence across startups and global CDMOs, including Lonza, Bellicum, and Celltex Therapeutics. As founder of DKO Consulting, he advises emerging biotechs on GMP readiness and Quality strategy. A University of Houston MBA and SUNY Plattsburgh biology graduate, Damola is dedicated to advancing regenerative medicine globally while mentoring the next generation of scientists and entrepreneurs. also aims to leverage his expertise to foster resilience in Africa’s biotech sector for future innovations and challenges